NCT04799873已完成不适用
Individual Treatment of COVID-19 by Application of Alpha-1-antitrypsin
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 10
- 试验地点
- 1
- 主要终点
- Clinical course
研究概览
简要总结
The blood concentrations of alpha-1-antitrypsin are monitored during COVID-19. The clinical course of patients that received AAT infusion for clinical indication is monitored.
详细描述
The blood concentrations of alpha-1-antitrypsin are monitored during COVID-19. The clinical course of patients that received AAT infusion for clinical indication is monitored. Clinical outcomes, blood inflammatory markers, and virus load are monitored.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 110 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Infection with SARS-COV2
- •Age over 18 years
排除标准
- •Unability to consent
- •Invasive ventilation
结局指标
主要结局
Clinical course
时间窗: 3 months
Disease course such as death, need for ICU treatment, ventilatory support or deterioration are monitored
次要结局
未报告次要终点
研究者
Robert Bals
Professor
Universität des Saarlandes
研究点 (1)
Loading locations...
相似试验
已完成
2 期
Personalised Immunotherapy for SARS-CoV-2 (COVID-19) Associated With Organ DysfunctionCOVID-19Virus DiseasesMacrophage Activation SyndromeCorona Virus InfectionNCT04339712Hellenic Institute for the Study of Sepsis102
Unknown
不适用
Management of Patients With Alpha-1 Antitrypsin Deficiency Associated EmphysemaAlpha 1-Antitrypsin DeficiencyEmphysemaNCT00700934Assistance Publique - Hôpitaux de Paris300
终止
2 期
ANTIBODY-LEVEL BASED ANALYSIS OF COVID-19 CONVALESCENT SERUM (ABACCuS)COVID-19Severe Acute Respiratory Syndrome (SARS)Coronavirus InfectionsNCT04432272William Beaumont Hospitals71
已完成
不适用
Human Ab Response & immunoMONItoring of COVID-19 PatientsSARS-CoV-2 CoronavirusAcute Respiratory Distress SyndromeNCT04373200Rennes University Hospital71
撤回
3 期
Anti-inflammatory Drug Algorithm for COVID-19 Home TreatmentCOVID-19NCT05249790Mario Negri Institute for Pharmacological Research1,800